Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1584)
  2. Meeting Abstract (783)
  3. Book Section (104)
  4. Review (68)
  5. Editorial (58)
  6. Research Letter (42)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1668)
  2. Survivorship Research (1183)
  3. Solid Tumor Oncology Division (1037)
  4. Department of Pathology and Laboratory Medicine (947)
  5. Surgery (939)
  6. Melanoma and Immunotherapeutics Service (783)

More Groups

People
  1. Klaus Busam (689)
  2. Daniel Coit (542)
  3. Allan Halpern (396)
  4. Michael Postow (362)
  5. Alexander Shoushtari (244)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (56)
  2. 2024 (136)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (264)
  2. Annals of Surgical Oncology (220)
  3. Journal of the American Academy of Dermatology (122)
  4. Journal of Investigative Dermatology (80)
  5. Modern Pathology (66)
  6. International Journal of Radiation Oncology, Biology, Physics (64)

More Publications

Publishers
  1. Springer (340)
  2. American Society of Clinical Oncology (279)
  3. Elsevier Inc. (227)
  4. Lippincott Williams & Wilkins (226)
  5. Wiley Blackwell (160)
  6. American Association for Cancer Research (157)

More Publishers

Results (2735)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunotherapy and transarterial embolization in patients with metastatic melanoma: A retrospective cohort study
    Journal Article

    Haghani, L.; Zhan, C.; Yarmohammadi, H.; Ziv, E.; Sotirchos, V. S.; Sarkar, D.; Shoushtari, A. N.; Erinjeri, J. P.
    Immunotherapy (2024)

    Fulltext@MSK | Save
  • Reply to comment on “Brief report: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to ‘false’ decreases in renal function”
    Correspondence

    Chen, M. F.; Wilhelm, C.; Drilon, A.; Gutgarts, V.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Minimizing the morbidity of mucosal melanoma with multimodality management
    Correspondence

    Williams, V. M.; Barker, C. A.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Baseline CD8 lymph node avidity with 89-Zr-crefmirlimab in patients with metastatic renal cell carcinoma and response to IO therapy
    Meeting Abstract

    Zang, P. D.; Twardowski, P.; Chen, D. L.; Hall, E. T.; Hays, D.; Wilson, I.; Schmiedehausen, K.; Ferris, M.; Le, W.; Postow, M. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses
    Meeting Abstract

    Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • RET inhibitors in RET fusion-positive lung cancers: Past, present, and future
    Review

    Chen, M. F.; Repetto, M.; Wilhelm, C.; Drilon, A.
    Drugs (2024)

    Fulltext@MSK | Save
  • Dermatologists’ perspectives and usage of large language models in practice: An exploratory survey
    Correspondence

    Gui, H.; Rezaei, S. J.; Schlessinger, D.; Weed, J.; Lester, J.; Wongvibulsin, S.; Mitchell, D.; Ko, J.; Rotemberg, V.; Lee, I.; more...
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Superficial Wnt-activated melanocytic nevi/melanocytomas with a junctional component: A case series
    Journal Article

    Ng, S.; Hall, K. C.; Busam, K. J.; Lezcano, C.; Moy, A. P.; Pulitzer, M.; Sriharan, A.; Yan, S.; Linos, K.
    American Journal of Dermatopathology (2024)

    Fulltext@MSK | Save
  • Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
    Journal Article

    Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma
    Journal Article

    Lochrin, S. E.; Cugliari, M. K.; Yeh, R.; Shoushtari, A. N.
    Melanoma Research (2024)

    Fulltext@MSK | Save